tetradecanoylphorbol acetate has been researched along with Liposarcoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kalinovsky, T; Monterrey, J; Niedzwiecki, A; Rath, M; Roomi, MW | 1 |
| Batarseh, A; Campioli, E; Li, J; Papadopoulos, V | 1 |
| Bhisey, RA; Ramchandani, AG; Sirsat, SM | 1 |
3 other study(ies) available for tetradecanoylphorbol acetate and Liposarcoma
| Article | Year |
|---|---|
In vitro modulation of MMP-2 and MMP-9 in adult human sarcoma cell lines by cytokines, inducers and inhibitors.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Antioxidants; Carcinogens; Catechin; Cell Line, Tumor; Chondrosarcoma; Dactinomycin; Dexamethasone; Doxycycline; Fibrosarcoma; Humans; Interleukin-1beta; Lipopolysaccharides; Liposarcoma; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Sarcoma; Sarcoma, Synovial; Tetradecanoylphorbol Acetate; Tretinoin; Tumor Necrosis Factor-alpha | 2013 |
The endocrine disruptor mono-(2-ethylhexyl) phthalate affects the differentiation of human liposarcoma cells (SW 872).
Topics: 3T3-L1 Cells; Adipocytes; Animals; Biomarkers; Bromodeoxyuridine; Cell Differentiation; Cell Line, Tumor; Diethylhexyl Phthalate; Endocrine Disruptors; Gene Knockdown Techniques; Humans; Liposarcoma; Mice; Peroxisome Proliferator-Activated Receptors; Protein Kinase C-epsilon; Receptors, GABA; RNA, Messenger; Tetradecanoylphorbol Acetate; Transcription, Genetic | 2011 |
Ultrastructure of chemically induced mouse skin tumours.
Topics: Animals; Carcinoma; Female; Fibrosarcoma; Keratoacanthoma; Liposarcoma; Methylcholanthrene; Mice; Rhabdomyosarcoma; Sarcoma, Experimental; Skin Neoplasms; Tetradecanoylphorbol Acetate | 1985 |